Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-05
2011-07-05
Goddard, Laura B (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387900
Reexamination Certificate
active
07973134
ABSTRACT:
The invention discloses 211 novel phosphorylation sites identified in signal transduction proteins and pathways underlying Anaplastic Large Cell Lymphoma (ALCL) involving the ALK-NPM translocation/fusion, and provides phosphorylation-site specific antibodies and heavy-isotope labeled peptides (AQUA peptides) for the selective detection and quantification of these phosphorylated sites/proteins, as well as methods of using the reagents for such purpose. Among the phosphorylation sites identified are sites occurring in the following protein types: Protein Kinases (including Receptor Tyrosine Kinases), Adaptor/Scaffold Proteins, Cellular Metabolism or Miscellaneous Enzymes, Oxidoreductases, Transcription Factors, Cytoskeletal Proteins, Translation Initiation Complexes, RNA Binding Proteins, Proteases, Acetyltransferases, G protein regulators/GTPases, Helicases, Apoptosis/Cell Cycle Regulation proteins, and Hydrolases.
REFERENCES:
patent: 3940475 (1976-02-01), Gross et al.
patent: 4289747 (1981-09-01), Chu et al.
patent: 4349893 (1982-09-01), Wiegman et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4474893 (1984-10-01), Reading et al.
patent: 4634664 (1987-01-01), Oestberg et al.
patent: 4634666 (1987-01-01), Engleman et al.
patent: 4659678 (1987-04-01), Forrest et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4727022 (1988-02-01), Skold et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5004692 (1991-04-01), Tso et al.
patent: 5092885 (1992-03-01), Yamada et al.
patent: 5112946 (1992-05-01), Maione et al.
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5202352 (1993-04-01), Okada et al.
patent: 5225539 (1993-07-01), Winter et al.
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5675063 (1997-10-01), Knight et al.
patent: 5677427 (1997-10-01), Goldenberg et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5789208 (1998-08-01), Sharon et al.
patent: 5969108 (1999-10-01), McCafferty et al.
patent: 6103889 (2000-08-01), Whitlow et al.
patent: 6120767 (2000-09-01), Robinson et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6329508 (2001-12-01), Friden et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6335163 (2002-01-01), Sharon et al.
patent: 6355245 (2002-03-01), Evans et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6407213 (2002-06-01), Carter et al.
patent: 6441140 (2002-08-01), Comb et al.
patent: 6462075 (2002-10-01), Bowen et al.
patent: 6465431 (2002-10-01), Thorn et al.
patent: 6475784 (2002-11-01), Papkoff et al.
patent: 6482802 (2002-11-01), Hu et al.
patent: 6482810 (2002-11-01), Brem et al.
patent: 6500431 (2002-12-01), Gill et al.
patent: 6500924 (2002-12-01), Brooks et al.
patent: 6518298 (2003-02-01), Green et al.
patent: 6521439 (2003-02-01), Folkman et al.
patent: 6525019 (2003-02-01), D'Amato et al.
patent: 6538103 (2003-03-01), Ji et al.
patent: 6544758 (2003-04-01), O'Reilly et al.
patent: 6544947 (2003-04-01), Holaday et al.
patent: 6548477 (2003-04-01), Olson et al.
patent: 6548640 (2003-04-01), Winter et al.
patent: 6559126 (2003-05-01), Tournaire et al.
patent: 6569845 (2003-05-01), Futamura et al.
patent: 6573256 (2003-06-01), Bishop et al.
patent: 6783961 (2004-08-01), Edwards et al.
patent: 6867007 (2005-03-01), Kauvar et al.
patent: 6884869 (2005-04-01), Senter et al.
patent: 6979557 (2005-12-01), Isogai et al.
patent: 7060268 (2006-06-01), Andya et al.
patent: 7109000 (2006-09-01), Edinger et al.
patent: 7198896 (2007-04-01), Rush et al.
patent: 7300753 (2007-11-01), Rush et al.
patent: 0120694 (1984-03-01), None
patent: 0239400 (1987-09-01), None
patent: 0404097 (1990-12-01), None
patent: 1184665 (2002-03-01), None
patent: WO 84/03508 (1984-09-01), None
patent: WO 85/03508 (1985-08-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 91/10741 (1991-07-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 93/11161 (1993-06-01), None
patent: WO 93/12227 (1993-06-01), None
patent: WO 95/20401 (1995-08-01), None
patent: WO 96/27011 (1996-06-01), None
patent: WO 02/00729 (2002-03-01), None
patent: WO 03/016861 (2003-02-01), None
patent: WO 03/089474 (2003-10-01), None
patent: WO 03/106644 (2003-12-01), None
patent: WO 2004/009618 (2004-01-01), None
patent: WO 2004/039963 (2004-05-01), None
patent: WO 2004/066957 (2004-08-01), None
patent: WO 2004/091658 (2004-10-01), None
patent: WO 2005/056825 (2005-06-01), None
patent: WO 2005/083444 (2005-09-01), None
PharMingen (Transduction Laboratories and PharMingen 1999 Cell Biology Sourcebook, 1999, pp. 242-245).
Glenney et al (J of Immunological Methods, 1988, 109:277-285).
Mammalian Gene Collection (MGC) Program Team “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.” Proc. Nat'l Acad. Sci. 99 (26): 16899-16903 (2002).
Haralambieva et al., “Tyrosine Phosphorylation in Human Lymphomas.” The Histochemical Journal 34: 545-552 (2002).
Zamo et al., “Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.” Oncogene (2002) 21: 1038-1047.
Bai et al., “Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphona is a Constitutively Active Tyrosine Kinase that Utilizes Phospholipase C-g to Mediate its Mitogenicity,” Molecular and Cellular Biology 18(12): 6951-6961 (1998).
Fujimoto et al., “Characterization of the transforming activity ofo80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5),” Proc. Nat'l Acad. Sci. 93: 4181-4186 (1996).
Watanabe et al, “Four Tyrosine Residues in Phospholipase C-gamma 2, Identified as Btk-dependent Phosphorylation Sites, Are Required for B Cell Antigen Receptor-coupled Calcium Signaling,” J. Biol. Chem. 276: 38595-38601 (2001).
Law et al., “Phospholipase C-gammal interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk”, Mol. Cell. Biol. 16(4): 1305-1315 (Apr. 1996).
White, M.F. “The IRS-signalling system: A network of docking proteins that mediate insulin action,” Molecular and Cellular Biochemistry 182: 3-11 (1998).
Van der Greer et al., “The SHC adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/Y240) tht mediate protein-protein interactions,” Current Biology 6(11): 1435-1444 (1996).
U.S. Appl. No. 10/408,486, filed Apr. 2003, Crosby et al.
U.S. Appl. No. 10/781,047, filed Feb. 17, 2004, Gygi et al.
U.S. Appl. No. 10/634,581, filed Aug. 2003, Johnson et al.
U.S. Appl. No. 10/821,234, filed Apr. 2004, Labat et al.
U.S. Appl. No. 11/077,717, filed Mar. 2005, Lam et al.
U.S. Appl. No. 11/089,368, filed Mar. 25, 2005, Ledbetter et al.
U.S. Appl. No. 11/049,630, filed Feb. 2, 2005, McKinsey et al.
Abu-Duhier et al., “Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukemia.” Br. J. Haematol. 113: 983-988 (2001).
Hardy, et al., “Clinical and Molecular Genetic Analysis of 19 Wolfram Syndrome Kindreds Demonstrating a Wide Spectrum of Mutations in WFS1”, Am. J. Hum. Genet. 65:1279-1290 (1999).
Dessein, et al., “Severe Hepatic Fibrosis inSchistoma mansoniInfection Is Controlled by a Major Locus That Is Closely Linked to the Interferon-y Receptor Gene”, Am. J. Hum. Genet. 65:709-721, (1999).
Di Barletta, et al., “Different Mutations in the LMNA Gene Cause Autosomal Dominant and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy”, Am. J. Hum. Genet. 66:1407-1412 (2000).
Ebrahimi, et al., “Murine Gammaherpesvirus-68 Infection Causes Multi-Organ Fibrosis and Alters Leukocyte Trafficking in Interfer
Lee Kimberly
Moritz Albrecht
Polakiewicz Roberto
Rush John
Cell Signaling Technology, Inc.
Goddard Laura B
Wilker Nancy Chiu
LandOfFree
Reagents for the detection of protein phosphorylation in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents for the detection of protein phosphorylation in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents for the detection of protein phosphorylation in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2726827